Coherus Biosciences Overview

Coherus Biosciences Selling, General & Admin

Selling, General & Admin expenses for CHRS.

Quarterly SG&A Expenses

$23.10M

↓ 11.22% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$97.68M

↓ 28.82% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin